TTMI insider files Form 144 to sell 25,000 shares valued at $1.01M
Rhea-AI Filing Summary
TTM Technologies (TTMI) Form 144 — The filing notifies a proposed sale of 25,000 common shares through Merrill Lynch on the NASDAQ with an aggregate market value of $1,011,401.28 and total outstanding shares reported as 103,313,274. The filing lists the securities being sold as acquired mainly through restricted stock unit awards (656 on 06/22/2021; 1,838 on 06/22/2023; 12,671 on 06/22/2024) and a performance award (9,835 on 02/22/2024). It also discloses a sale on 06/23/2025 of 13,669 shares for gross proceeds of $496,868.53. The signer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Detailed acquisition history is disclosed (RSUs and performance awards with dates and quantities)
- Broker and market details provided (Merrill Lynch; NASDAQ; approximate sale date 08/19/2025), supporting transparency
- Signer certifies no undisclosed material adverse information, consistent with Form 144 attestations
Negative
- Significant proposed insider sale of 25,000 shares valued at $1,011,401.28 could represent material insider liquidity
- Recent prior sale on 06/23/2025 of 13,669 shares for $496,868.53 indicates multiple near-term insider dispositions
Insights
TL;DR: Routine insider liquidity event: proposed sale of 25,000 shares (~$1.01M) after prior June sale of 13,669 shares.
The Form 144 documents a proposed sale by an insider or related person of 25,000 common shares via Merrill Lynch on NASDAQ, valued at roughly $1.01 million. The filing also itemizes the original acquisition sources — restricted stock units and a performance award — with specific grant dates and quantities, which provides clear provenance of the shares being sold. A recent sale on 06/23/2025 of 13,669 shares for $496,868.53 is disclosed, indicating recent insider liquidity. This filing is procedural and informational; it does not assert any change in company operations or financial condition.
TL;DR: Disclosure aligns with Rule 144 requirements; no allegations of undisclosed material information are made.
The submission includes required details: broker, sale date, share counts, outstanding shares, aggregate market value, and acquisition history (RSUs and performance awards). The signer affirms lack of undisclosed material adverse information and cites Rule 10b5-1 trading-plan language. From a governance perspective, the form shows standardized compliance with transfer and reporting obligations but does reflect meaningful insider selling activity totaling the proposed 25,000 shares and a recent June sale.